|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 159.58 USD | +2.42% |
|
+2.09% | -12.63% |
| 10-14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| 10-08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.42% | +2.09% | -22.34% | -28.00% | -12.63% | +21.26% | +148.37% | +280.77% | +2,083.04% | 8.16B | |
| +3.49% | +10.04% | +10.20% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,106B | |
| +2.19% | +4.32% | -3.75% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 612B | |
| +2.26% | +5.37% | +9.30% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 500B | |
| +2.58% | +8.31% | +9.28% | +16.67% | +18.80% | +37.43% | +63.51% | +8.93% | +66.77% | 367B | |
| +3.25% | +4.45% | -0.80% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 354B | |
| +1.85% | +5.45% | +9.90% | +1.20% | +15.42% | +21.38% | +49.26% | +64.95% | +68.89% | 286B | |
| +1.76% | +4.92% | +0.94% | +0.19% | -8.50% | +0.48% | +20.31% | +44.39% | +155.40% | 256B | |
| +3.29% | +6.32% | +11.64% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 230B | |
| +2.25% | +5.81% | +3.95% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 190B | |
| +1.83% | +1.87% | -7.23% | -20.82% | -19.69% | -23.77% | -61.82% | -22.03% | +89.07% | 170B | |
| +2.28% | +6.13% | +8.54% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 168B | |
| +2.53% | +6.07% | +0.77% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 127B | |
| +4.84% | +8.84% | -1.50% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 120B | |
| +1.95% | +7.09% | +16.20% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 118B | |
| +0.73% | +5.51% | -0.48% | -2.50% | +2.41% | +14.98% | +28.76% | +6.23% | -10.22% | 99B | |
| +3.62% | +2.77% | -0.63% | -4.86% | -11.05% | -14.87% | -25.53% | -10.95% | +7.38% | 95.44B | |
| +6.69% | +11.94% | +39.98% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 90.58B | |
| +3.25% | +7.22% | +1.17% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 78.09B | |
| +1.42% | +5.59% | +12.75% | +7.41% | +19.41% | +30.48% | -2.43% | -24.94% | +48.19% | 70.41B | |
| Average | +2.88% | +2.02% | +4.89% | +21.95% | +48.89% | +64.69% | +54.42% | +94.77% | +323.36% | 252.26B | |
| Weighted average by Cap. | +3.04% | +2.34% | +5.87% | +15.31% | +31.64% | +48.92% | +68.30% | +151.95% | +468.62% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
